Search research articles
Contact Us
Filters
Showing results (211-220 of 282) with videos related to
Page
of 29
Sort By:
British Journal of Pharmacology
|
June 9, 2026
Identification, reliability, and validity of drug-drug interaction checkers in chronic diseases: A systematic review
Brayden Ng Gibson, Sri Chodapuneedi, Huan Yee Koh, et al.
Antiviral Therapy
|
June 3, 2010
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Catia Marzolini, Luigia Elzi, Sara Gibbons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial
Alan Winston, Janaki Amin, Amanda Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2021
Total and Unbound Doravirine Concentrations and Viral Suppression in CSF
Juan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, et al.
Antiviral Therapy
|
March 24, 2020
Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial
Alejandro Arenas-Pinto, Wolfgang Stöhr, Saye Khoo, et al.
Ebiomedicine
|
August 20, 2015
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
Nathan W Cummins, Jacqueline Neuhaus, Haitao Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2023
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin
Kamunkhwala Gausi, Henry Mugerwa, Marco Siccardi, et al.
The Journal of Infectious Diseases
|
June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction
Sudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
Infectious Diseases and Therapy
|
February 19, 2024
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study
Juan Ambrosioni, Natalia Anahí Díaz, Catia Marzolini, et al.
The Journal of Antimicrobial Chemotherapy
|
March 29, 2011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
Alessandro Schipani, Christoph Wyen, Tabitha Mahungu, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 282) with videos related to
Sort By:
Page
of 29
British Journal of Pharmacology
|
June 9, 2026
Identification, reliability, and validity of drug-drug interaction checkers in chronic diseases: A systematic review
Brayden Ng Gibson, Sri Chodapuneedi, Huan Yee Koh, et al.
Antiviral Therapy
|
June 3, 2010
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Catia Marzolini, Luigia Elzi, Sara Gibbons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial
Alan Winston, Janaki Amin, Amanda Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2021
Total and Unbound Doravirine Concentrations and Viral Suppression in CSF
Juan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, et al.
Antiviral Therapy
|
March 24, 2020
Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial
Alejandro Arenas-Pinto, Wolfgang Stöhr, Saye Khoo, et al.
Ebiomedicine
|
August 20, 2015
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
Nathan W Cummins, Jacqueline Neuhaus, Haitao Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2023
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin
Kamunkhwala Gausi, Henry Mugerwa, Marco Siccardi, et al.
The Journal of Infectious Diseases
|
June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction
Sudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
Infectious Diseases and Therapy
|
February 19, 2024
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study
Juan Ambrosioni, Natalia Anahí Díaz, Catia Marzolini, et al.
The Journal of Antimicrobial Chemotherapy
|
March 29, 2011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
Alessandro Schipani, Christoph Wyen, Tabitha Mahungu, et al.
Page
of 29